AbbVie Spotlights Its Early-Stage R&D Pipeline

 
• By John Davis

A group of early-stage investigational cancer, myelofibrosis and immune-oncology products have been tagged by AbbVie as potential therapies of interest longer term.  

OilPipes
A full product pipeline is required by major pharmaceutical companies • Source: Shutterstock

More from Clinical Trials

More from R&D